Conduit secures a composition of matter patent from the USPTO for its lead asset, AZD1656, a Glucokinase Activator targeting autoimmune disorders, positioning the Company for clinical development and ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...

Corebridge Financial Inc. lessened its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $55.0, with a high ...

We recently published a list of 11 Blue Chip Stocks to Invest in at 52-Week Lows. In this article, we are going to take a ...

Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge ...

Swiss National Bank increased its stake in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) by 34.4% during the 4th ...

Fintel reports that on March 31, 2025, Piper Sandler initiated coverage of Centessa Pharmaceuticals plc - Depositary Receipt () (NasdaqGS:CNTA) with a Overweight recommendation. Analyst Price ...

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at ...

Even still, the pharma deals announced out of the event brought a clear message for the biotech industry. Technology ...

As of December 31, 2024, Fortress' consolidated cash and cash equivalents totaled $57.3 million, compared to $58.9 million as ...

Conduit Pharmaceuticals advances its pipeline with ... its IP portfolio and optimize the formulation of its pipeline assets. In the laboratory, the Company is evaluating the assets licensed ...